| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_785ac2b35073f5a6d251678e6fb31b6f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-582 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 |
| filingDate |
2002-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_347aab33450a1b2c8918d430a82dd3c5 |
| publicationDate |
2003-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003225256-A1 |
| titleOfInvention |
Antisense modulation of pctaire protein kinase 2 expression |
| abstract |
Antisense compounds, compositions and methods are provided for modulating the expression of PCTAIRE protein kinase 2. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PCTAIRE protein kinase 2. Methods of using these compounds for modulation of PCTAIRE protein kinase 2 expression and for treatment of diseases associated with expression of PCTAIRE protein kinase 2 are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10787669-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10370667-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010138806-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2435571-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2435571-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9840710-B2 |
| priorityDate |
2002-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |